Position in NTLA
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$1,865,463
+$523,877 QoQ
Shares Held
145,512
-2.5% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NTLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PINNACLE ASSOCIATES LTD holds $159,188,901 across 24 Biotechnology names. NTLA ranks #11 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
82,512 | $63,752,071 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
436,457 | $32,773,556 | |
| 3 | CYTK |
Cytokinetics Inc
|
177,062 | $11,670,156 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
175,456 | $11,001,091 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,590 | $9,640,798 | |
| 6 | STTK |
Shattuck Labs, Inc.
|
1,368,223 | $8,797,673 | |
| 7 | INCY |
Incyte Corp
|
68,019 | $6,401,948 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
74,956 | $5,106,752 |
All Filings in NTLA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,865,463 | 145,512 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,341,586 | 149,231 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,827,271 | 163,710 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,588,503 | 169,350 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,527,370 | 214,820 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,567,205 | 220,172 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $5,619,125 | 251,078 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $7,034,747 | 255,716 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||